Frank D. Lee - Jan 2, 2025 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jan 2, 2025
Transactions value $
-$171,844
Form type
4
Date filed
1/6/2025, 06:23 PM
Previous filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability -$172K -9.38K -8.7% $18.33 98.4K Jan 2, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.